NeuroBo Pharmaceuticals Inc (NRBO)
2.41
-0.15
(-5.86%)
USD |
NASDAQ |
Nov 14, 16:00
2.37
-0.04
(-1.66%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Research and Development Expense (Quarterly): 4.517M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.517M |
| June 30, 2024 | 8.074M |
| March 31, 2024 | 4.904M |
| December 31, 2023 | 3.865M |
| September 30, 2023 | 2.292M |
| June 30, 2023 | 2.364M |
| March 31, 2023 | 0.637M |
| December 31, 2022 | 0.305M |
| September 30, 2022 | 0.571M |
| June 30, 2022 | 0.982M |
| March 31, 2022 | 0.92M |
| December 31, 2021 | 1.997M |
| September 30, 2021 | 1.394M |
| June 30, 2021 | 2.012M |
| March 31, 2021 | 1.143M |
| December 31, 2020 | 17.78M |
| September 30, 2020 | 1.265M |
| June 30, 2020 | 0.674M |
| March 31, 2020 | 2.152M |
| December 31, 2019 | 13.58M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.15M |
| June 30, 2019 | 0.948M |
| March 31, 2019 | 1.80M |
| December 31, 2018 | 1.402M |
| September 30, 2018 | 3.542M |
| June 30, 2018 | 3.96M |
| March 31, 2018 | 4.977M |
| December 31, 2017 | 5.08M |
| September 30, 2017 | 6.489M |
| June 30, 2017 | 5.837M |
| March 31, 2017 | 5.28M |
| December 31, 2016 | 4.839M |
| September 30, 2016 | 1.936M |
| June 30, 2016 | 0.789M |
| March 31, 2016 | 1.176M |
| December 31, 2015 | 1.464M |
| September 30, 2015 | 1.369M |
| June 30, 2015 | 0.952M |
| March 31, 2015 | 1.114M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.305M
Minimum
Dec 2022
17.78M
Maximum
Dec 2020
3.571M
Average
2.004M
Median
Research and Development Expense (Quarterly) Benchmarks
| Cytokinetics Inc | -- |
| Ocugen Inc | 8.108M |
| enVVeno Medical Corp | 2.859M |
| Scholar Rock Holding Corp | 42.37M |
| Mirum Pharmaceuticals Inc | 32.67M |